Stock Under $10 with 50-100% upside potential - 14 Days FREE!

10 Best Life Sciences Stocks for 2013

Top Rated Stocks

Every day TheStreet Ratings produces a list of the top rated stocks. These 10 life sciences stocks are rated highest by our methodology.

Equity Top: Life Sciences Tools & Services


Source: TheStreet Ratings

Best Investments for 2013

Life Sciences

Article
Here are today's top research calls.
5/24/13 8:04AM
Article
Biotech columnist Adam Feuerstein answers readers' questions about health-care companies.
5/24/13 7:00AM
Article
Here's why we took a position in the iShares NASDAQ Biotechnology Index.
5/23/13 6:07AM
Article
What Ben Bernanke says may have some effect on the market, but not much, Cramer said.
5/22/13 7:45PM
Article
Sodastream has lost its fizz, Cramer said, but Salesforce.com will beat the estimates.
5/22/13 5:10PM
Article
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
5/22/13 4:29PM
Article
The pace of deals among developers of antibiotics is about to ramp higher.
5/22/13 7:00AM
Article
Two charts show how investors feel differently about Keryx and Acadia Pharma.
5/21/13 10:38AM
Article
One trader believes Rockwell shares will rise into clinical trial results expected in July.
5/21/13 8:00AM
Article
An updated list of the biotech and drug firms expecting FDA drug approval decisions in 2013.
5/21/13 7:00AM
Article
Investors in PROLOR Biotech, Inc. saw new options begin trading today, for the July expiration.
5/20/13 4:01PM
Article
Another entrepreneurial U.S. startup bites the dust... sort of.
5/20/13 2:27PM
Article
Actavis took the offensive in plans to acquire specialty pharmaceuticals firm Warner Chilcott plc for $8.5 billion in stock and assumed debt.
5/20/13 10:01AM
Article
TheStreet's senior columnist Adam Feuerstein and Gregg Greenberg discuss winners and losers from research abstracts ahead of the ASCO cancer conference.
5/17/13 10:44AM
Article
Biotech columnist Adam Feuerstein answers readers' questions about health-care companies.
5/17/13 7:00AM

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 15,303.10 8.60 0.06%
NASDAQ 3,459.14 -0.28 -0.01%
S&P 500 1,649.60 -0.91 -0.06%
US 10 Yr 2.011% -0.012

Brokerage Partners

Advertising Partners

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.

Top Rated Stocks Top Rated Funds Top Rated ETFs